Aesthetic Medical International Holdings Group (Aesthetic Medical International Holdings Group) 3-Year EBITDA Growth Rate : 0.00% (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Aesthetic Medical International Holdings Group 3-Year EBITDA Growth Rate?

Aesthetic Medical International Holdings Group's EBITDA per Share for the three months ended in Jun. 2023 was $-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aesthetic Medical International Holdings Group was 91.50% per year. The lowest was -166.40% per year. And the median was -101.10% per year.

Competitive Comparison of Aesthetic Medical International Holdings Group's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Aesthetic Medical International Holdings Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aesthetic Medical International Holdings Group's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aesthetic Medical International Holdings Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Aesthetic Medical International Holdings Group's 3-Year EBITDA Growth Rate falls into.

Aesthetic Medical International Holdings Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Aesthetic Medical International Holdings Group (NAS:AIH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Aesthetic Medical International Holdings Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Aesthetic Medical International Holdings Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aesthetic Medical International Holdings Group (Aesthetic Medical International Holdings Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aesthetic Medical International Holdings Group Ltd (NAS:AIH) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

3FMA:Germany 3FMA:Germany

Address

1122 Nanshan Boulevard, Nanshan District, Guangdong Province, Shenzhen, CHN, 518052

Website

https://ir.aihgroup.net

Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from four service offerings: non-surgical aesthetic medical services, surgical aesthetic medical services, other aesthetic medical services, and general healthcare services in the People's Republic of China. The company derives a majority of its revenue from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.